ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Allarity Therapeutics Inc

Allarity Therapeutics Inc (ALLR)

1.12
0.06
(5.66%)
Cerrado 10 Marzo 2:00PM
1.13
0.01
( 0.89% )
Pre Mercado: 3:51AM

Su centro para precios en tiempo real, ideas y debates en vivo

Estadísticas y detalles clave

Último Precio
1.13
Postura de Compra
1.12
Postura de Venta
1.13
Volume Operado de la Acción
26,800
0.00 Rango del Día 0.00
0.6775 Rango de 52 semanas 250.80
Capitalización de Mercado [m]
Precio Anterior
1.12
Precio de Apertura
-
Última hora de negociación
04:46:20
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
2,522,625
Acciones en circulación
4,433,587
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-0.24
Beneficio por acción (BPA)
-4.6
turnover
-
Beneficio neto
-20.42M

Acerca de Allarity Therapeutics Inc

Allarity Therapeutics Inc is a clinical-stage, precision medicine company. Allarity Therapeutics Inc is a clinical-stage, precision medicine company.

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sitio web
Sede
Wilmington, Delaware, USA
Fundado
-
Allarity Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ALLR. The last closing price for Allarity Therapeutics was US$1.12. Over the last year, Allarity Therapeutics shares have traded in a share price range of US$ 0.6775 to US$ 250.80.

Allarity Therapeutics currently has 4,433,587 shares in issue. The market capitalisation of Allarity Therapeutics is US$4.97 million. Allarity Therapeutics has a price to earnings ratio (PE ratio) of -0.24.

ALLR Últimas noticias

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10.2528.40909090910.881.240.8340899221.04832421CS
40.087.619047619051.051.240.677522795140.960263CS
120.186819.80491942320.94321.990.677525226251.10056877CS
26-1.72-60.3508771932.853.950.677514354131.33032136CS
52-249.67-99.5494417863250.8250.80.6775322244716.58205559CS
15645775.3661523-100.002468638-45774.236152392640-43684.955664120294571590.70348855CS
260250334.919414-100.000451397-250333.78941492640-167332.37365218957671286.82990071CS

ALLR - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Allarity Therapeutics?
El precio actual de las acciones de Allarity Therapeutics es US$ 1.13
¿Cuántas acciones de Allarity Therapeutics están en circulación?
Allarity Therapeutics tiene 4,433,587 acciones en circulación
¿Cuál es la capitalización de mercado de Allarity Therapeutics?
La capitalización de mercado de Allarity Therapeutics es USD 4.97M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Allarity Therapeutics?
Allarity Therapeutics ha negociado en un rango de US$ 0.6775 a US$ 250.80 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Allarity Therapeutics?
El ratio precio/beneficio de Allarity Therapeutics es -0.24
¿Cuál es la moneda de reporte de Allarity Therapeutics?
Allarity Therapeutics presenta sus resultados financieros en USD
¿Cuál es el último beneficio anual de Allarity Therapeutics?
El último beneficio anual de Allarity Therapeutics es USD -20.42M
¿Cuál es la dirección registrada de Allarity Therapeutics?
La dirección registrada de Allarity Therapeutics es 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
¿Cuál es la dirección del sitio web de Allarity Therapeutics?
La dirección del sitio web de Allarity Therapeutics es www.allarity.com
¿En qué sector industrial opera Allarity Therapeutics?
Allarity Therapeutics opera en el sector PHARMACEUTICAL PREPARATIONS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
AWHAspira Womans Health Inc
US$ 0.3519
(77.73%)
33.58M
TSVT2seventy bio Inc
US$ 4.94
(76.43%)
376.56k
TNONTenon Medical Inc
US$ 2.01
(60.80%)
7.85M
ADTNADTRAN Holdings Inc
US$ 11.49
(35.34%)
41
REEREE Automotive Ltd
US$ 7.00
(30.35%)
15
MBXMBX Biosciences Inc
US$ 5.01
(-44.21%)
2
NEOGNeogen Corporation
US$ 6.03
(-39.58%)
8
JANXJanux Therapeutics Inc
US$ 20.05
(-33.65%)
22
SVRASavara Inc
US$ 2.01
(-24.44%)
4
LZMHLZ Technology Holdings Ltd
US$ 12.01
(-23.31%)
193
AWHAspira Womans Health Inc
US$ 0.3519
(77.73%)
33.58M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 7.96
(7.86%)
14.65M
BTOGBit Origin Ltd
US$ 0.5348
(12.57%)
12.12M
CUTRCutera Inc
US$ 0.1524
(18.60%)
8.82M
TNONTenon Medical Inc
US$ 2.01
(60.80%)
7.85M

ALLR Discussion

Ver más
shurtha2000 shurtha2000 7 horas hace
How much is a fully funded P2 Trial $20M-$30M ??
👍️0
shurtha2000 shurtha2000 19 horas hace
When we hit 5M volume look out above
👍️0
shurtha2000 shurtha2000 19 horas hace
Nice volume getting serious
👍️0
kindo kindo 1 día hace
https://substack.com/inbox/post/158047254?utm_campaign=post&triedRedirect=true
👍️0
Golden Cross Golden Cross 1 día hace
50 - 100% potential here next week
👎️ 1 🤢 1
Golden Cross Golden Cross 3 días hace
$ALLR A Biotech Turnaround With FDA Fast-Track Potential
https://docs.google.com/document/u/0/d/18xKdntXBscs8Qpbx3DUZJCPhEPuLPOly3G1UonXYNeo/mobilebasic?pli=1
👍️ 1 👎️ 1 💎 1 💯 1 🤢 1
Golden Cross Golden Cross 4 días hace
Loaded more today. Think we see $1.20+ next week. Get past $1.20 and should see $2 pretty quick..ALLR
👍️0
Golden Cross Golden Cross 4 días hace
Monster news yesterday!!!

$ALLR
👍️ 1 👎️ 1 💎 1 💯 1 🤢 1 ⭐️ 1
Golden Cross Golden Cross 5 días hace
$ALLR Allarity Therapeutics Announces Phase 2 Trial of Stenoparib in Combination with Temozolomide for Recurrent Small Cell Lung Cancer Fully Funded by the US Veterans Administration
https://finance.yahoo.com/news/allarity-therapeutics-announces-phase-2-130000563.html
👍️ 1 💎 1 💯 1 🤢 1
georgie18 georgie18 5 días hace
ALLR...$1.19...🥳

georgie18

Member Level
Re: georgie18 post# 676239

Wednesday, March 05, 2025 3:58:44 PM

Post#
676296
of 676322
ALLR...$1.09...Trying to Breakout here...🥳

georgie18

Member Level
Re: georgie18 post# 390871

Wednesday, March 05, 2025 1:44:05 PM

Post#
390872
of 390880
ALLR...$1.02...🥳...Psar flipped Bullish...Hit $1.05 Resistance at the 50ma...Lets see if ALLR can Break/Hold $1.05 and Breakout...

georgie18

Member Level
Re: georgie18 post# 676181

Wednesday, March 05, 2025 12:17:51 PM

Post#
676229
of 676236
ALLR...22,000 share buy @ 9782...🥳

georgie18

Member Level
Re: georgie18 post# 390833

Wednesday, March 05, 2025 9:45:01 AM

Post#
390865
of 390870
ALLR...96...Added here...🥳

georgie18

Member Level
Re: georgie18 post# 675910

Tuesday, March 04, 2025 7:48:48 AM

Post#
676027
of 676179
ALLR...92...🥳...Hit $1.01...

georgie18

Member Level
Re: georgie18 post# 390813

Monday, March 03, 2025 9:50:54 AM

Post#
390818
of 390832
ALLR...9455...🥳

georgie18

Member Level
Re: georgie18 post# 675278

Monday, March 03, 2025 8:07:22 AM

Post#
675893
of 675909
ALLR...88...🥳...5 Million dollar board approved repurchase program...announced this morning...

georgie18

Member Level
Re: georgie18 post# 390587

Monday, February 24, 2025 10:52:12 AM

Post#
390694
of 390812
ALLR...79...Added the dip...🥳... https://www.globenewswire.com/news-release/2025/02/24/3031065/0/en/Allarity-Therapeutics-to-Begin-Enrollment-for-New-Phase-2-Protocol-to-Advance-Stenoparib-Toward-FDA-Approval-in-Advanced-Ovarian-Cancer-Patients.html

georgie18

Member Level
Re: georgie18 post# 674892

Friday, February 21, 2025 9:36:04 AM

Post#
675048
of 675277
ALLR...97s clearing here...🥳...Off the .90 range bottom...

georgie18

Member Level
Re: georgie18 post# 389759

Thursday, February 20, 2025 10:06:24 AM

Post#
390508
of 390586
ALLR...Loading .90s...🥳...averaging down...$1.03

georgie18

Member Level
Re: georgie18 post# 673394

Thursday, February 06, 2025 8:08:38 AM

Post#
673498
of 674891
ALLR...$1.23...🥳... https://www.globenewswire.com/news-release/2025/02/06/3021970/0/en/Allarity-Therapeutics-Announces-Expansion-of-Phase-2-Clinical-Trial-to-Accelerate-Development-of-Stenoparib-in-Advanced-Ovarian-Cancer.html
👍️0
Golden Cross Golden Cross 5 días hace
Targeting 1.50
👍️0
georgie18 georgie18 6 días hace
ALLR...$1.09...Trying to Breakout here...🥳

georgie18

Member Level
Re: georgie18 post# 390871

Wednesday, March 05, 2025 1:44:05 PM

Post#
390872
of 390880
ALLR...$1.02...🥳...Psar flipped Bullish...Hit $1.05 Resistance at the 50ma...Lets see if ALLR can Break/Hold $1.05 and Breakout...

georgie18

Member Level
Re: georgie18 post# 676181

Wednesday, March 05, 2025 12:17:51 PM

Post#
676229
of 676236
ALLR...22,000 share buy @ 9782...🥳

georgie18

Member Level
Re: georgie18 post# 390833

Wednesday, March 05, 2025 9:45:01 AM

Post#
390865
of 390870
ALLR...96...Added here...🥳

georgie18

Member Level
Re: georgie18 post# 675910

Tuesday, March 04, 2025 7:48:48 AM

Post#
676027
of 676179
ALLR...92...🥳...Hit $1.01...

georgie18

Member Level
Re: georgie18 post# 390813

Monday, March 03, 2025 9:50:54 AM

Post#
390818
of 390832
ALLR...9455...🥳

georgie18

Member Level
Re: georgie18 post# 675278

Monday, March 03, 2025 8:07:22 AM

Post#
675893
of 675909
ALLR...88...🥳...5 Million dollar board approved repurchase program...announced this morning...

georgie18

Member Level
Re: georgie18 post# 390587

Monday, February 24, 2025 10:52:12 AM

Post#
390694
of 390812
ALLR...79...Added the dip...🥳... https://www.globenewswire.com/news-release/2025/02/24/3031065/0/en/Allarity-Therapeutics-to-Begin-Enrollment-for-New-Phase-2-Protocol-to-Advance-Stenoparib-Toward-FDA-Approval-in-Advanced-Ovarian-Cancer-Patients.html

georgie18

Member Level
Re: georgie18 post# 674892

Friday, February 21, 2025 9:36:04 AM

Post#
675048
of 675277
ALLR...97s clearing here...🥳...Off the .90 range bottom...

georgie18

Member Level
Re: georgie18 post# 389759

Thursday, February 20, 2025 10:06:24 AM

Post#
390508
of 390586
ALLR...Loading .90s...🥳...averaging down...$1.03

georgie18

Member Level
Re: georgie18 post# 673394

Thursday, February 06, 2025 8:08:38 AM

Post#
673498
of 674891
ALLR...$1.23...🥳... https://www.globenewswire.com/news-release/2025/02/06/3021970/0/en/Allarity-Therapeutics-Announces-Expansion-of-Phase-2-Clinical-Trial-to-Accelerate-Development-of-Stenoparib-in-Advanced-Ovarian-Cancer.html
👍️0
georgie18 georgie18 6 días hace
ALLR...$1.02...🥳...Psar flipped Bullish...Hit $1.05 Resistance at the 50ma...Lets see if ALLR can Break/Hold $1.05 and Breakout...

georgie18

Member Level
Re: georgie18 post# 676181

Wednesday, March 05, 2025 12:17:51 PM

Post#
676229
of 676236
ALLR...22,000 share buy @ 9782...🥳

georgie18

Member Level
Re: georgie18 post# 390833

Wednesday, March 05, 2025 9:45:01 AM

Post#
390865
of 390870
ALLR...96...Added here...🥳

georgie18

Member Level
Re: georgie18 post# 675910

Tuesday, March 04, 2025 7:48:48 AM

Post#
676027
of 676179
ALLR...92...🥳...Hit $1.01...

georgie18

Member Level
Re: georgie18 post# 390813

Monday, March 03, 2025 9:50:54 AM

Post#
390818
of 390832
ALLR...9455...🥳

georgie18

Member Level
Re: georgie18 post# 675278

Monday, March 03, 2025 8:07:22 AM

Post#
675893
of 675909
ALLR...88...🥳...5 Million dollar board approved repurchase program...announced this morning...

georgie18

Member Level
Re: georgie18 post# 390587

Monday, February 24, 2025 10:52:12 AM

Post#
390694
of 390812
ALLR...79...Added the dip...🥳... https://www.globenewswire.com/news-release/2025/02/24/3031065/0/en/Allarity-Therapeutics-to-Begin-Enrollment-for-New-Phase-2-Protocol-to-Advance-Stenoparib-Toward-FDA-Approval-in-Advanced-Ovarian-Cancer-Patients.html

georgie18

Member Level
Re: georgie18 post# 674892

Friday, February 21, 2025 9:36:04 AM

Post#
675048
of 675277
ALLR...97s clearing here...🥳...Off the .90 range bottom...

georgie18

Member Level
Re: georgie18 post# 389759

Thursday, February 20, 2025 10:06:24 AM

Post#
390508
of 390586
ALLR...Loading .90s...🥳...averaging down...$1.03

georgie18

Member Level
Re: georgie18 post# 673394

Thursday, February 06, 2025 8:08:38 AM

Post#
673498
of 674891
ALLR...$1.23...🥳... https://www.globenewswire.com/news-release/2025/02/06/3021970/0/en/Allarity-Therapeutics-Announces-Expansion-of-Phase-2-Clinical-Trial-to-Accelerate-Development-of-Stenoparib-in-Advanced-Ovarian-Cancer.html
👍️0
georgie18 georgie18 6 días hace
ALLR...22,000 share buy @ 9782...🥳

georgie18

Member Level
Re: georgie18 post# 390833

Wednesday, March 05, 2025 9:45:01 AM

Post#
390865
of 390870
ALLR...96...Added here...🥳

georgie18

Member Level
Re: georgie18 post# 675910

Tuesday, March 04, 2025 7:48:48 AM

Post#
676027
of 676179
ALLR...92...🥳...Hit $1.01...

georgie18

Member Level
Re: georgie18 post# 390813

Monday, March 03, 2025 9:50:54 AM

Post#
390818
of 390832
ALLR...9455...🥳

georgie18

Member Level
Re: georgie18 post# 675278

Monday, March 03, 2025 8:07:22 AM

Post#
675893
of 675909
ALLR...88...🥳...5 Million dollar board approved repurchase program...announced this morning...

georgie18

Member Level
Re: georgie18 post# 390587

Monday, February 24, 2025 10:52:12 AM

Post#
390694
of 390812
ALLR...79...Added the dip...🥳... https://www.globenewswire.com/news-release/2025/02/24/3031065/0/en/Allarity-Therapeutics-to-Begin-Enrollment-for-New-Phase-2-Protocol-to-Advance-Stenoparib-Toward-FDA-Approval-in-Advanced-Ovarian-Cancer-Patients.html

georgie18

Member Level
Re: georgie18 post# 674892

Friday, February 21, 2025 9:36:04 AM

Post#
675048
of 675277
ALLR...97s clearing here...🥳...Off the .90 range bottom...

georgie18

Member Level
Re: georgie18 post# 389759

Thursday, February 20, 2025 10:06:24 AM

Post#
390508
of 390586
ALLR...Loading .90s...🥳...averaging down...$1.03

georgie18

Member Level
Re: georgie18 post# 673394

Thursday, February 06, 2025 8:08:38 AM

Post#
673498
of 674891
ALLR...$1.23...🥳... https://www.globenewswire.com/news-release/2025/02/06/3021970/0/en/Allarity-Therapeutics-Announces-Expansion-of-Phase-2-Clinical-Trial-to-Accelerate-Development-of-Stenoparib-in-Advanced-Ovarian-Cancer.html
👍️0
georgie18 georgie18 6 días hace
ALLR...96...Added here...🥳

georgie18

Member Level
Re: georgie18 post# 675910

Tuesday, March 04, 2025 7:48:48 AM

Post#
676027
of 676179
ALLR...92...🥳...Hit $1.01...

georgie18

Member Level
Re: georgie18 post# 390813

Monday, March 03, 2025 9:50:54 AM

Post#
390818
of 390832
ALLR...9455...🥳

georgie18

Member Level
Re: georgie18 post# 675278

Monday, March 03, 2025 8:07:22 AM

Post#
675893
of 675909
ALLR...88...🥳...5 Million dollar board approved repurchase program...announced this morning...

georgie18

Member Level
Re: georgie18 post# 390587

Monday, February 24, 2025 10:52:12 AM

Post#
390694
of 390812
ALLR...79...Added the dip...🥳... https://www.globenewswire.com/news-release/2025/02/24/3031065/0/en/Allarity-Therapeutics-to-Begin-Enrollment-for-New-Phase-2-Protocol-to-Advance-Stenoparib-Toward-FDA-Approval-in-Advanced-Ovarian-Cancer-Patients.html

georgie18

Member Level
Re: georgie18 post# 674892

Friday, February 21, 2025 9:36:04 AM

Post#
675048
of 675277
ALLR...97s clearing here...🥳...Off the .90 range bottom...

georgie18

Member Level
Re: georgie18 post# 389759

Thursday, February 20, 2025 10:06:24 AM

Post#
390508
of 390586
ALLR...Loading .90s...🥳...averaging down...$1.03

georgie18

Member Level
Re: georgie18 post# 673394

Thursday, February 06, 2025 8:08:38 AM

Post#
673498
of 674891
ALLR...$1.23...🥳... https://www.globenewswire.com/news-release/2025/02/06/3021970/0/en/Allarity-Therapeutics-Announces-Expansion-of-Phase-2-Clinical-Trial-to-Accelerate-Development-of-Stenoparib-in-Advanced-Ovarian-Cancer.html
👍️0
stocktowatch stocktowatch 7 días hace
$ALLR Allarity Therapeutics (ALLR): A Biotech Turnaround With FDA Fast-Track Potential
https://docs.google.com/document/d/18xKdntXBscs8Qpbx3DUZJCPhEPuLPOly3G1UonXYNeo/mobilebasic
👍️0
georgie18 georgie18 7 días hace
ALLR...92...🥳...Hit $1.01...

georgie18

Member Level
Re: georgie18 post# 390813

Monday, March 03, 2025 9:50:54 AM

Post#
390818
of 390832
ALLR...9455...🥳

georgie18

Member Level
Re: georgie18 post# 675278

Monday, March 03, 2025 8:07:22 AM

Post#
675893
of 675909
ALLR...88...🥳...5 Million dollar board approved repurchase program...announced this morning...

georgie18

Member Level
Re: georgie18 post# 390587

Monday, February 24, 2025 10:52:12 AM

Post#
390694
of 390812
ALLR...79...Added the dip...🥳... https://www.globenewswire.com/news-release/2025/02/24/3031065/0/en/Allarity-Therapeutics-to-Begin-Enrollment-for-New-Phase-2-Protocol-to-Advance-Stenoparib-Toward-FDA-Approval-in-Advanced-Ovarian-Cancer-Patients.html

georgie18

Member Level
Re: georgie18 post# 674892

Friday, February 21, 2025 9:36:04 AM

Post#
675048
of 675277
ALLR...97s clearing here...🥳...Off the .90 range bottom...

georgie18

Member Level
Re: georgie18 post# 389759

Thursday, February 20, 2025 10:06:24 AM

Post#
390508
of 390586
ALLR...Loading .90s...🥳...averaging down...$1.03

georgie18

Member Level
Re: georgie18 post# 673394

Thursday, February 06, 2025 8:08:38 AM

Post#
673498
of 674891
ALLR...$1.23...🥳... https://www.globenewswire.com/news-release/2025/02/06/3021970/0/en/Allarity-Therapeutics-Announces-Expansion-of-Phase-2-Clinical-Trial-to-Accelerate-Development-of-Stenoparib-in-Advanced-Ovarian-Cancer.html
👍️0
glenn1919 glenn1919 1 semana hace
ALLR.................................https://stockcharts.com/h-sc/ui?s=ALLR&p=W&b=5&g=0&id=p86431144783
👍️0
georgie18 georgie18 1 semana hace
ALLR...9455...🥳

georgie18

Member Level
Re: georgie18 post# 675278

Monday, March 03, 2025 8:07:22 AM

Post#
675893
of 675909
ALLR...88...🥳...5 Million dollar board approved repurchase program...announced this morning...

georgie18

Member Level
Re: georgie18 post# 390587

Monday, February 24, 2025 10:52:12 AM

Post#
390694
of 390812
ALLR...79...Added the dip...🥳... https://www.globenewswire.com/news-release/2025/02/24/3031065/0/en/Allarity-Therapeutics-to-Begin-Enrollment-for-New-Phase-2-Protocol-to-Advance-Stenoparib-Toward-FDA-Approval-in-Advanced-Ovarian-Cancer-Patients.html

georgie18

Member Level
Re: georgie18 post# 674892

Friday, February 21, 2025 9:36:04 AM

Post#
675048
of 675277
ALLR...97s clearing here...🥳...Off the .90 range bottom...

georgie18

Member Level
Re: georgie18 post# 389759

Thursday, February 20, 2025 10:06:24 AM

Post#
390508
of 390586
ALLR...Loading .90s...🥳...averaging down...$1.03

georgie18

Member Level
Re: georgie18 post# 673394

Thursday, February 06, 2025 8:08:38 AM

Post#
673498
of 674891
ALLR...$1.23...🥳... https://www.globenewswire.com/news-release/2025/02/06/3021970/0/en/Allarity-Therapeutics-Announces-Expansion-of-Phase-2-Clinical-Trial-to-Accelerate-Development-of-Stenoparib-in-Advanced-Ovarian-Cancer.html
👍️0
georgie18 georgie18 1 semana hace
ALLR...88...🥳...5 Million dollar board approved repurchase program...announced this morning...

georgie18

Member Level
Re: georgie18 post# 390587

Monday, February 24, 2025 10:52:12 AM

Post#
390694
of 390812
ALLR...79...Added the dip...🥳... https://www.globenewswire.com/news-release/2025/02/24/3031065/0/en/Allarity-Therapeutics-to-Begin-Enrollment-for-New-Phase-2-Protocol-to-Advance-Stenoparib-Toward-FDA-Approval-in-Advanced-Ovarian-Cancer-Patients.html

georgie18

Member Level
Re: georgie18 post# 674892

Friday, February 21, 2025 9:36:04 AM

Post#
675048
of 675277
ALLR...97s clearing here...🥳...Off the .90 range bottom...

georgie18

Member Level
Re: georgie18 post# 389759

Thursday, February 20, 2025 10:06:24 AM

Post#
390508
of 390586
ALLR...Loading .90s...🥳...averaging down...$1.03

georgie18

Member Level
Re: georgie18 post# 673394

Thursday, February 06, 2025 8:08:38 AM

Post#
673498
of 674891
ALLR...$1.23...🥳... https://www.globenewswire.com/news-release/2025/02/06/3021970/0/en/Allarity-Therapeutics-Announces-Expansion-of-Phase-2-Clinical-Trial-to-Accelerate-Development-of-Stenoparib-in-Advanced-Ovarian-Cancer.html
👍️0
Millenium323 Millenium323 2 semanas hace
ALLR could be trading at $4.00 based on its cash alone. It currently has a sub $4 million dollar market cap. According to yesterdays press release, "Allarity expects to pursue multiple advantaged regulatory pathways to expedite approval in the first half of 2025. Allarity will also be presenting key data, with abstracts now accepted, at multiple upcoming scientific and clinical conferences." I expect this to be trading much higher in the very near future. The current price and market cap make little sense and are artificially low especially for a cancer stock with a drug showing promise in Phase 2.

https://finance.yahoo.com/news/allarity-therapeutics-begin-enrollment-phase-130000704.html
👍️0
Acehole Acehole 2 semanas hace
Just another pharma scam company. CEO Thomas "Jackass" Jenson is collecting nearly $50k/month salary while he defrauds investors. The company needs $30 Million to do their trial. They have perhaps $15 Million cash on hand right now with a monthly burn rate of about $500k. There are ZERO institutional investors. Jackass Jenson is going to dilute shareholders into oblivion for the rest of the year. There is no chance they stay listed on Nasdaq. Do NOT invest a penny here.
👍️0
Monksdream Monksdream 2 semanas hace
ALLR, new 52 week low
👍️0
MC10459 MC10459 2 semanas hace
This was at $250 pps a year ago. This thing dropped like a rock. Someone tell me why those days aren't long gone.
👍️0
georgie18 georgie18 2 semanas hace
ALLR...79...Added the dip...🥳... https://www.globenewswire.com/news-release/2025/02/24/3031065/0/en/Allarity-Therapeutics-to-Begin-Enrollment-for-New-Phase-2-Protocol-to-Advance-Stenoparib-Toward-FDA-Approval-in-Advanced-Ovarian-Cancer-Patients.html

georgie18

Member Level
Re: georgie18 post# 674892

Friday, February 21, 2025 9:36:04 AM

Post#
675048
of 675277
ALLR...97s clearing here...🥳...Off the .90 range bottom...

georgie18

Member Level
Re: georgie18 post# 389759

Thursday, February 20, 2025 10:06:24 AM

Post#
390508
of 390586
ALLR...Loading .90s...🥳...averaging down...$1.03

georgie18

Member Level
Re: georgie18 post# 673394

Thursday, February 06, 2025 8:08:38 AM

Post#
673498
of 674891
ALLR...$1.23...🥳... https://www.globenewswire.com/news-release/2025/02/06/3021970/0/en/Allarity-Therapeutics-Announces-Expansion-of-Phase-2-Clinical-Trial-to-Accelerate-Development-of-Stenoparib-in-Advanced-Ovarian-Cancer.html
👍️0
omda omda 2 semanas hace
Hey to all, When the clinical trials are concluded with the stenoparib will this get an FDA approved?
👍️0
georgie18 georgie18 3 semanas hace
ALLR...97s clearing here...🥳...Off the .90 range bottom...

georgie18

Member Level
Re: georgie18 post# 389759

Thursday, February 20, 2025 10:06:24 AM

Post#
390508
of 390586
ALLR...Loading .90s...🥳...averaging down...$1.03

georgie18

Member Level
Re: georgie18 post# 673394

Thursday, February 06, 2025 8:08:38 AM

Post#
673498
of 674891
ALLR...$1.23...🥳... https://www.globenewswire.com/news-release/2025/02/06/3021970/0/en/Allarity-Therapeutics-Announces-Expansion-of-Phase-2-Clinical-Trial-to-Accelerate-Development-of-Stenoparib-in-Advanced-Ovarian-Cancer.html
👍️0
georgie18 georgie18 3 semanas hace
ALLR...Loading .90s...🥳...averaging down...$1.03

georgie18

Member Level
Re: georgie18 post# 673394

Thursday, February 06, 2025 8:08:38 AM

Post#
673498
of 674891
ALLR...$1.23...🥳... https://www.globenewswire.com/news-release/2025/02/06/3021970/0/en/Allarity-Therapeutics-Announces-Expansion-of-Phase-2-Clinical-Trial-to-Accelerate-Development-of-Stenoparib-in-Advanced-Ovarian-Cancer.html
👍️0
stocktowatch stocktowatch 4 semanas hace
$ALLR An in-depth review of Allarity’s maturing clinical data, in collaboration with leading clinical investigators, prompted Allarity to design this new Phase 2 protocol to enable a more aggressive push of stenoparib toward regulatory approval. The protocol will enable new enrollment expressly focusing on patients with advanced, recurrent, platinum-resistant disease, a group that has shown durable clinical benefit from stenoparib in the current phase 2 trial and who have only limited treatment options following standard chemotherapy. In addition to expanding and deepening the clinical data set necessary for regulatory approval, this trial is also designed to enhance the understanding of stenoparib’s unique therapeutic mechanism of action. Of particular interest will be the impact of stenoparib treatment on the Wnt pathway, a key cellular pathway repeatedly shown to be involved in advanced ovarian cancers as well as many other advanced cancer types, most notably colon cancers. A richer understanding of stenoparib’s potential for controlling the Wnt pathway—a key aspect of the newly designed trial—could further distinguish stenoparib as a unique investigational cancer treatment.
👍️0
stocktowatch stocktowatch 1 mes hace
$ALLR News - Allarity Therapeutics Announces Expansion of Phase 2 Clinical Trial to Accelerate Development of Stenoparib in Advanced Ovarian Cancer
https://finance.yahoo.com/news/allarity-therapeutics-announces-expansion-phase-130000934.html
👍️ 1
georgie18 georgie18 1 mes hace
ALLR...$1.23...🥳... https://www.globenewswire.com/news-release/2025/02/06/3021970/0/en/Allarity-Therapeutics-Announces-Expansion-of-Phase-2-Clinical-Trial-to-Accelerate-Development-of-Stenoparib-in-Advanced-Ovarian-Cancer.html
👍️0
georgie18 georgie18 1 mes hace
ALLR...$1.15...Trying to turn up here...🥳
👍️0
omda omda 1 mes hace
What's happening to this company, will it become bankrupt and permanently delisted. I gave it a thumbs up for cancer research. Was fraud detected in the company financials report or maybe the clinic trials have failed. Any comments on this?
👍️0
georgie18 georgie18 1 mes hace
ALLR...$1.19...Reversing off the $1 LOD...🥳
👍️0
koolmc koolmc 1 mes hace
1.20s from 1 dip, get it past 1.30's again chance for bigger move imo
👍️0
stocktowatch stocktowatch 1 mes hace
$ALLR Allarity Therapeutics (ALLR): A Biotech Turnaround With FDA Fast-Track Potential

1. The Troubled Past: Poor Leadership and Financial Mismanagement
Allarity Therapeutics was once plagued by severe financial mismanagement, regulatory concerns, and questionable leadership. The company faced Wells Notices, an SEC investigation, and disastrous financing decisions, leaving investors uncertain about its future.

Key Issues Under Previous Leadership:
? Wells Notices & SEC Investigation: The company was under regulatory scrutiny for past financial decisions. (Source)

? Dilutive Financing: Multiple rounds of toxic financing and poor capital structure decisions led to massive shareholder dilution. (Source)

? Stock Price Collapse & Nasdaq Compliance Issues: Due to financial mismanagement, the company faced delisting threats from Nasdaq. (Source)
👍️0
luckydude777 luckydude777 1 mes hace
If I was a Market Maker, I would do to this stock what has been DONE to it this last week. Attempt to break the confidence of everyone connected with the company so cheaper shares could be accumulated.

CHEAPER SHARES?!!!!!!!!!!!!!!!!!!!

Sure. Market Makers KNOW that companies like ATTR who are devoting their time and talent to helping cure people of cancerous issues are WORTH far more than any AI stock you can buy right now.

Watch disgruntled AI chip investors TURN to a sector that is trying to extend the quality of life for humanity. ALLR fits the bill for me.
👍️0
koolmc koolmc 1 mes hace
peeps were expecting news yesterday besides the settlement
👍️0
Millenium323 Millenium323 1 mes hace
$ALLR only has a market cap of around $6 million with a drug in Phase 2 clinical trials. It should be trading at $20 per share right now. Oh well it looks like I will be adding. No one ever said the stock market was efficient.
👍️0
georgie18 georgie18 1 mes hace
ALLR...$1.23...Bouncing off the $1.12 dip...🥳
👍️0
LonesomeGeorge LonesomeGeorge 1 mes hace
Well, this is fantastic.
👍️0
koolmc koolmc 1 mes hace
grabbed some 1.17's on dip heading into the data release.
👍️0
LonesomeGeorge LonesomeGeorge 1 mes hace
Wtf?
👍️0
georgie18 georgie18 1 mes hace
ALLR...$1.36...🥳 ... https://www.globenewswire.com/news-release/2025/01/30/3017967/0/en/Allarity-Therapeutics-Announces-Filing-of-Form-8-K-Regarding-Settlement-Agreement-in-Principle-with-SEC.html
👍️0
15for2 15for2 1 mes hace
looked like a low volume stop-loss sweep, imo
could get really interesting this afternoon
$ALLR
👍️0
LonesomeGeorge LonesomeGeorge 1 mes hace
Wtf?
👍️0
luckydude777 luckydude777 1 mes hace
RNAZ flying today with little more than speculation. Has more shares outstanding than ALLR and no assurance it has medicine any better than ALLR's ... far as anyone is sharing right now.

I'm looking for ALLR to start climbing near the close today and maybe higher in A/H.s. Tomorrow morning should get a lot of generous upside going into the mid-afternoon if all goes well.
👍️0
luckydude777 luckydude777 1 mes hace
Added to the treasure chest some of those $1.49's.
👍️0
luckydude777 luckydude777 1 mes hace
$ALLR presenting tomorrow approx 2:15 pm
Fasten your seatbelts
👍️0
boston127 boston127 1 mes hace
I need toi follow your alerts.

Good call.
👍️0

Su Consulta Reciente

Delayed Upgrade Clock